LicianPro

Celularity Inc ·

CELU 8-K 2026-09-28

Celularity Inc (CELU) 8-K dated 2026-09-28 — accession 0001493152-26-044421.

Celularity Inc (CELU) is a biotechnology company listed on US.

Celularity Inc filed a 8-K on 2026-09-28. Accession 0001493152-26-044421.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03), Unregistered share sale (Item 3.02), Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CELU revenue for 2025-12-31 was $26.6M. Net income was -$91.7M. Revenue was down 51.0% from 2024-12-31 to 2025-12-31. CELU currently screens at market cap $25.2M.

Not investment advice. The CELU SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr